Abstract
Acutemyeloid leukemia (AML) is a devastating disease with poor patient survival. As targetable mutations in AML are rare, novel oncogenic mechanisms a......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
